Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/11/2025

Management of Erythematous Flat Rash in HIV Patient on Antiretrovirals

Immediate Assessment and Critical Exclusions

  • The American College of Physicians recommends assessing for severe cutaneous adverse reactions (SCAR) that require immediate hospitalization, according to the British Journal of Pharmacology 1, 2
  • Check for mucosal involvement, blistering, skin exfoliation, or detachment suggesting Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 1
  • Measure fever, as temperature >39°C indicates severe hypersensitivity requiring immediate drug cessation, according to the British Journal of Pharmacology 2
  • Calculate body surface area (BSA) involvement to grade severity, as recommended by Praxis Medical Insights 1
  • Evaluate for DRESS syndrome, looking for lymphadenopathy, hepatitis, or other organ involvement, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 1

Most Likely Diagnosis: Naproxen-Induced Cutaneous Reaction

  • HIV antiretrovirals remain a consideration but are less likely if the patient has been stable on medications without recent changes, according to the British Journal of Pharmacology and Praxis Medical Insights 2, 3, 1
  • Antiretroviral hypersensitivity typically occurs within the first weeks of therapy, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 1

Immediate Management Algorithm

  • Discontinue naproxen immediately and permanently, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 3
  • Apply topical emollients and mild-to-moderate potency topical corticosteroids to affected areas, as recommended by Praxis Medical Insights 1
  • Prescribe oral antihistamines for symptomatic relief of pruritus, as recommended by Praxis Medical Insights 3, 1

Laboratory Workup

  • Obtain baseline studies to assess severity and rule out systemic involvement, including complete blood count and comprehensive metabolic panel, as recommended by Praxis Medical Insights and the British Journal of Pharmacology 1, 4, 2

Critical Pitfalls to Avoid

  • Never use prophylactic corticosteroids or antihistamines when restarting medications known to cause rash, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 1
  • Never rechallenge with naproxen if confirmed as the causative agent, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 3
  • Avoid sedating antihistamines in elderly or at-risk patients due to fall and cognitive impairment risk, as recommended by Praxis Medical Insights 1, 4

Dermatology Referral Indications

  • Refer urgently if no response to initial treatment after 2 weeks, diagnostic uncertainty exists, autoimmune skin disease suspected, or rash progresses despite appropriate management, as recommended by Praxis Medical Insights 1, 4

Follow-Up Monitoring

  • Monitor weekly if Grade 2 until improvement to Grade 1, as recommended by Praxis Medical Insights 4
  • Immediate consultation required if fever develops, mucosal involvement appears, or systemic symptoms emerge, as recommended by the British Journal of Pharmacology and Praxis Medical Insights 2, 1

REFERENCES

1

Initial Workup and Treatment for a Patient Presenting with Rash [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

hypersensitivity reactions to hiv therapy. [LINK]

British Journal of Pharmacology, 2011

3

Duration of Hives Rash After Stopping Truvada [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Initial Management of Polyarthalgia with Skin Rash [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025